These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 3029317

  • 1. Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections.
    Linde A, Andersson J, Lundgren G, Wahren B.
    J Med Virol; 1987 Feb; 21(2):109-21. PubMed ID: 3029317
    [Abstract] [Full Text] [Related]

  • 2. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients.
    Hadar T, Rahima M, Kahan E, Sidi J, Rakowsky E, Sarov B, Sarov I.
    J Med Virol; 1986 Dec; 20(4):329-39. PubMed ID: 3025351
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW, Myrmel H.
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [Abstract] [Full Text] [Related]

  • 4. Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma.
    Kaschka WP, Hilgers R, Skvaril F.
    Clin Exp Immunol; 1982 Jul; 49(1):149-56. PubMed ID: 6290114
    [Abstract] [Full Text] [Related]

  • 5. [IgA antibodies against Epstein-Barr virus capsid antigen].
    Chalupa P, Slesinger P, Krchnáková A, Prásek J.
    Cas Lek Cesk; 1992 Sep 10; 131(17):526-9. PubMed ID: 1330312
    [Abstract] [Full Text] [Related]

  • 6. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H, Nowak R, Donner A, Kunkel M, Gärtner L, Scholtz HJ.
    Acta Virol; 1983 May 10; 27(3):277-81. PubMed ID: 6138990
    [Abstract] [Full Text] [Related]

  • 7. Development of immunity to Epstein-Barr virus in Malaysian children.
    Yadav MS, Malliga N, Ablashi DV.
    Microbiologica; 1987 Jan 10; 10(1):29-35. PubMed ID: 3033449
    [Abstract] [Full Text] [Related]

  • 8. Assessment of serologic markers for Epstein-Barr virus.
    Swanston W, Mahony J, McLaughlin B, Chernesky M.
    Diagn Microbiol Infect Dis; 1986 Sep 10; 5(3):235-44. PubMed ID: 3019605
    [Abstract] [Full Text] [Related]

  • 9. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G, Bitzer M, Bross KJ, Brugger W, Boldt C, Hirsch FW, Weitzmann U, Löhr GW.
    Dtsch Med Wochenschr; 1984 Nov 30; 109(48):1837-43. PubMed ID: 6094138
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.
    Shinkura R, Yamamoto N, Koriyama C, Shinmura Y, Eizuru Y, Tokunaga M.
    J Med Virol; 2000 Apr 30; 60(4):411-6. PubMed ID: 10686024
    [Abstract] [Full Text] [Related]

  • 11. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.
    Cancer; 2004 Mar 15; 100(6):1162-70. PubMed ID: 15022282
    [Abstract] [Full Text] [Related]

  • 12. Avidities of IgG directed against viral capsid antigen or early antigen: useful markers for significant Epstein-Barr virus serology.
    Andersson A, Vetter V, Kreutzer L, Bauer G.
    J Med Virol; 1994 Jul 15; 43(3):238-44. PubMed ID: 7931184
    [Abstract] [Full Text] [Related]

  • 13. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
    Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, Indrasari SR, Kusumo H, Zeng YS, Schouten T, Mubarika S, Middeldorp JM.
    J Clin Microbiol; 2006 Apr 15; 44(4):1459-67. PubMed ID: 16597877
    [Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus serology in bone marrow transplantations: a one-year retrospective study with detection of EBV IgM-VCA-specific antibodies.
    Morinet F, Icart J, Ruelle C, Gluckman E, Perol Y.
    J Med Virol; 1986 Apr 15; 18(4):349-60. PubMed ID: 3011981
    [Abstract] [Full Text] [Related]

  • 15. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M, Rezbová M, Svecová M, Hrbácková H, Novotná M, Ochotná J, Roubalová K.
    Klin Mikrobiol Infekc Lek; 2004 Aug 15; 10(4):186-90. PubMed ID: 15328576
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma.
    Tiwawech D, Srivatanakul P, Karaluk A, Ishida T.
    Asian Pac J Cancer Prev; 2003 Aug 15; 4(2):113-8. PubMed ID: 12875623
    [Abstract] [Full Text] [Related]

  • 20. Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia.
    Dölken G, Bross KJ, Hecht T, Brugger W, Löhr GW, Hirsch FW.
    Int J Cancer; 1986 Jul 15; 38(1):55-9. PubMed ID: 3013785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.